281 related articles for article (PubMed ID: 12727852)
1. Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration.
Udayakumar TS; Chen ML; Bair EL; Von Bredow DC; Cress AE; Nagle RB; Bowden GT
Cancer Res; 2003 May; 63(9):2292-9. PubMed ID: 12727852
[TBL] [Abstract][Full Text] [Related]
2. Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration.
Bair EL; Chen ML; McDaniel K; Sekiguchi K; Cress AE; Nagle RB; Bowden GT
Neoplasia; 2005 Apr; 7(4):380-9. PubMed ID: 15967115
[TBL] [Abstract][Full Text] [Related]
3. Membrane-type matrix metalloproteinase-1 (MT1-MMP) is a processing enzyme for human laminin gamma 2 chain.
Koshikawa N; Minegishi T; Sharabi A; Quaranta V; Seiki M
J Biol Chem; 2005 Jan; 280(1):88-93. PubMed ID: 15525652
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic processing of laminin-5 by MT1-MMP in tissues and its effects on epithelial cell morphology.
Koshikawa N; Schenk S; Moeckel G; Sharabi A; Miyazaki K; Gardner H; Zent R; Quaranta V
FASEB J; 2004 Feb; 18(2):364-6. PubMed ID: 14688206
[TBL] [Abstract][Full Text] [Related]
5. Membrane type 1-matrix metalloproteinase promotes human prostate cancer invasion and metastasis.
Cao J; Chiarelli C; Kozarekar P; Adler HL
Thromb Haemost; 2005 Apr; 93(4):770-8. PubMed ID: 15841326
[TBL] [Abstract][Full Text] [Related]
6. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.
Seftor RE; Seftor EA; Koshikawa N; Meltzer PS; Gardner LM; Bilban M; Stetler-Stevenson WG; Quaranta V; Hendrix MJ
Cancer Res; 2001 Sep; 61(17):6322-7. PubMed ID: 11522618
[TBL] [Abstract][Full Text] [Related]
7. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5.
Koshikawa N; Giannelli G; Cirulli V; Miyazaki K; Quaranta V
J Cell Biol; 2000 Feb; 148(3):615-24. PubMed ID: 10662785
[TBL] [Abstract][Full Text] [Related]
8. Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion.
Giannelli G; Bergamini C; Fransvea E; Marinosci F; Quaranta V; Antonaci S
Lab Invest; 2001 Apr; 81(4):613-27. PubMed ID: 11304581
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
[TBL] [Abstract][Full Text] [Related]
10. Contribution of MT1-MMP and of human laminin-5 gamma2 chain degradation to mammary epithelial cell migration.
Gilles C; Polette M; Coraux C; Tournier JM; Meneguzzi G; Munaut C; Volders L; Rousselle P; Birembaut P; Foidart JM
J Cell Sci; 2001 Aug; 114(Pt 16):2967-76. PubMed ID: 11686300
[TBL] [Abstract][Full Text] [Related]
11. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration.
Kajita M; Itoh Y; Chiba T; Mori H; Okada A; Kinoh H; Seiki M
J Cell Biol; 2001 May; 153(5):893-904. PubMed ID: 11381077
[TBL] [Abstract][Full Text] [Related]
12. Expression and localization of membrane-type-1 matrix metalloproteinase, CD 44, and laminin-5gamma2 chain during colorectal carcinoma tumor progression.
Murai S; Umemiya T; Seiki M; Harigaya K
Virchows Arch; 2004 Sep; 445(3):271-8. PubMed ID: 15517370
[TBL] [Abstract][Full Text] [Related]
13. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia.
Upadhyay J; Shekarriz B; Nemeth JA; Dong Z; Cummings GD; Fridman R; Sakr W; Grignon DJ; Cher ML
Clin Cancer Res; 1999 Dec; 5(12):4105-10. PubMed ID: 10632347
[TBL] [Abstract][Full Text] [Related]
14. Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) on prostate cancer cell lines.
Nagakawa O; Murakami K; Yamaura T; Fujiuchi Y; Murata J; Fuse H; Saiki I
Cancer Lett; 2000 Jul; 155(2):173-9. PubMed ID: 10822133
[TBL] [Abstract][Full Text] [Related]
15. Relation between laminin-5 gamma 2 chain and cell surface metalloproteinase MT1-MMP in clear cell carcinoma of the ovary.
Kato N; Motoyama T
Int J Gynecol Pathol; 2009 Jan; 28(1):49-54. PubMed ID: 19047908
[TBL] [Abstract][Full Text] [Related]
16. Prinomastat, a hydroxamate inhibitor of matrix metalloproteinases, has a complex effect on migration of breast carcinoma cells.
Deryugina EI; Ratnikov BI; Strongin AY
Int J Cancer; 2003 May; 104(5):533-41. PubMed ID: 12594807
[TBL] [Abstract][Full Text] [Related]
17. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan.
Büttner FH; Hughes CE; Margerie D; Lichte A; Tschesche H; Caterson B; Bartnik E
Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):159-65. PubMed ID: 9639575
[TBL] [Abstract][Full Text] [Related]
18. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
19. Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein-1 is a new member of the Cupin superfamily. A possible multifunctional protein acting as an invasion suppressor down-regulated in tumors.
Uekita T; Gotoh I; Kinoshita T; Itoh Y; Sato H; Shiomi T; Okada Y; Seiki M
J Biol Chem; 2004 Mar; 279(13):12734-43. PubMed ID: 14718544
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma.
Guo P; Imanishi Y; Cackowski FC; Jarzynka MJ; Tao HQ; Nishikawa R; Hirose T; Hu B; Cheng SY
Am J Pathol; 2005 Mar; 166(3):877-90. PubMed ID: 15743799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
